ARTICLE | Company News
Magen, Eli Lilly deal
January 14, 2008 8:00 AM UTC
Eli Lilly granted Magen exclusive, worldwide rights to develop and commercialize a series of undisclosed preclinical compounds for dermatology applications. Further terms were not disclosed. ...